2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

Author:

Wann L. Samuel1,Curtis Anne B.1,Ellenbogen Kenneth A.2,Estes N.A. Mark34,Ezekowitz Michael D.14,Jackman Warren M.1,January Craig T.1,Lowe James E.1,Page Richard L.2,Slotwiner David J.24,Stevenson William G.5,Tracy Cynthia M.1

Affiliation:

1. ACCF/AHA Representative.

2. HRS Representative.

3. ACCF/AHA Task Force on Performance Measures Representative.

4. Recused from voting on Section 8.1.4.2.5, Recommendation for Use of Oral Direct Thrombin Inhibitor Anticoagulant Agents.

5. ACCF/AHA Task Force on Practice Guidelines Liaison.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference7 articles.

1. ACCF/AHA Task Force on Practice Guidelines. Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines . Available at: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf and http://circ.ahajournals.org/manual/. Last update July 20 2010. Accessed January 3 2011

2. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

3. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

4. Newly Identified Events in the RE-LY Trial

5. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Cited by 367 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3